Zimmer Biomet
883 hedge funds and large institutions have $21.5B invested in Zimmer Biomet in 2019 Q2 according to their latest regulatory filings, with 76 funds opening new positions, 296 increasing their positions, 312 reducing their positions, and 75 closing their positions.
1% more first-time investments, than exits
New positions opened: 76 | Existing positions closed: 75
0% more funds holding in top 10
Funds holding in top 10: 19 → 19 (0)
0.42% less ownership
Funds ownership: 92.45% → 92.02% (-0.42%)
5% less repeat investments, than reductions
Existing positions increased: 296 | Existing positions reduced: 312
2% less funds holding
Funds holding: 897 → 883 (-14)
8% less capital invested
Capital invested by funds: $23.4B → $21.5B (-$1.91B)
43% less call options, than puts
Call options by funds: $30.5M | Put options by funds: $53.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nuveen
Charlotte,
North Carolina
|
+$500M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$267M |
| 3 |
Boston Partners
Boston,
Massachusetts
|
+$254M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$69M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$67.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LP
Longview Partners
St Peter Port,
Guernsey
|
-$294M |
| 2 |
JP Morgan Chase
New York
|
-$176M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$137M |
| 4 |
HM
HealthCor Management
New York
|
-$136M |
| 5 |
Millennium Management
New York
|
-$130M |
ZBH Hedge Fund Activity: Q2 2019 in Review
883 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in Zimmer Biomet (ZBH) for Q2 2019, worth a combined $21.5B — down 8.2% from $23.4B a quarter earlier.
Buyers outnumbered sellers: 76 funds opened new ZBH positions and 75 closed out — a net gain of 1 holder — while 296 added to existing stakes and 312 trimmed.
The largest buyer was Nuveen, adding an estimated $500M. The largest seller was Longview Partners, exiting entirely with an estimated $294M sold.
- 883 institutional investors held Zimmer Biomet (ZBH) as of Q2 2019, down from 897 in Q1 2019.
- Funds reported $21.5B of Zimmer Biomet stock for Q2 2019, down 8.2% quarter-over-quarter.
- 76 funds opened new Zimmer Biomet positions in Q2 2019 and 75 closed out, a net change of +1 holder.
- The largest Zimmer Biomet buyer in Q2 2019 was Nuveen, an estimated $500M added.
- The largest Zimmer Biomet seller in Q2 2019 was Longview Partners, an estimated $294M sold.
Based on aggregated 13F filings for Q2 2019.